Prosper Dna Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$350K
- Investors
-
5
Prosper Dna General Information
Description
Developer of canine genetic testing technology designed to help dog owners better understand their pets through advanced DNA and epigenetic analysis. The company's technology utilizes whole-genome sequencing, epigenetic DNA methylation analysis, oral microbiome profiling, and proprietary genetic analysis to assess breed composition, inherited health risks, biological age, personality traits, and oral health, enabling dog owners and veterinarians to make informed decisions that support preventive care and improve canine health and well-being.
Contact Information
Website
www.prosperk9.comCorporate Office
- 9410 Owensmouth Avenue
- Chatsworth
- Los Angeles, CA 91311
- United States
Corporate Office
- 9410 Owensmouth Avenue
- Chatsworth
- Los Angeles, CA 91311
- United States
Prosper Dna Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 23-Dec-2020 | $350K | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 09-Jan-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Prosper Dna Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Prosper Dna Patents
Prosper Dna Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220238233-A1 | Epigenetics-based health and disease assessments for treatment and wellness recommendations | Inactive | 23-May-2019 | ||
| WO-2020237048-A1 | Epigenetics-based health and disease assessments for treatment and wellness recommendations | Inactive | 23-May-2019 |
Prosper Dna Signals
Prosper Dna Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sage Venture Partners | Venture Capital | Minority | ||
| Seedstars International Ventures | Venture Capital | Minority | ||
| Global Insurance Accelerator | Accelerator/Incubator | Minority | ||
| Magnify | Accelerator/Incubator | Minority | ||
| MiLA Capital | Venture Capital | Minority |
Prosper Dna FAQs
-
When was Prosper Dna founded?
Prosper Dna was founded in 2017.
-
Where is Prosper Dna headquartered?
Prosper Dna is headquartered in Los Angeles, CA.
-
What is the size of Prosper Dna?
Prosper Dna has 5 total employees.
-
What industry is Prosper Dna in?
Prosper Dna’s primary industry is Other Consumer Non-Durables.
-
Is Prosper Dna a private or public company?
Prosper Dna is a Private company.
-
What is the current valuation of Prosper Dna?
The current valuation of Prosper Dna is .
-
What is Prosper Dna’s current revenue?
The current revenue for Prosper Dna is .
-
How much funding has Prosper Dna raised over time?
Prosper Dna has raised $390K.
-
Who are Prosper Dna’s investors?
Sage Venture Partners, Seedstars International Ventures, Global Insurance Accelerator, Magnify, and MiLA Capital have invested in Prosper Dna.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process